These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 34219522)
1. Psychosis in Parkinson's Disease: Current Treatment Options and Impact on Patients and Caregivers. Segal GS; Xie SJ; Paracha SU; Grossberg GT J Geriatr Psychiatry Neurol; 2021 Jul; 34(4):274-279. PubMed ID: 34219522 [TBL] [Abstract][Full Text] [Related]
2. Pimavanserin, a novel antipsychotic for management of Parkinson's disease psychosis. Kianirad Y; Simuni T Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1161-1168. PubMed ID: 28817967 [TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease and Parkinson's disease psychosis: a perspective on the challenges, treatments, and economic burden. Fredericks D; Norton JC; Atchison C; Schoenhaus R; Pill MW Am J Manag Care; 2017 Apr; 23(5 Suppl):S83-S92. PubMed ID: 28715903 [TBL] [Abstract][Full Text] [Related]
4. Hallucinations and delusions associated with Parkinson's disease psychosis: safety of current treatments and future directions. Isaacson SH; Citrome L Expert Opin Drug Saf; 2022 Jul; 21(7):873-879. PubMed ID: 35466847 [TBL] [Abstract][Full Text] [Related]
5. Psychosis in Parkinson's Disease: Looking Beyond Dopaminergic Treatments. Rojas M; Chávez-Castillo M; Duran P; Ortega Á; Bautista-Sandoval MJ; Salazar J; Riaño-Garzón M; Chacín M; Medina-Ortiz O; Palmar J; Cudris-Torres L; Bermúdez V Curr Pharm Des; 2022; 28(33):2725-2741. PubMed ID: 36321314 [TBL] [Abstract][Full Text] [Related]
6. Changing the treatment paradigm for Parkinson's disease psychosis with pimavanserin. Lyons KE; Pahwa R; Hermanowicz N; Davis T; Pagan F; Isaacson S Expert Rev Clin Pharmacol; 2019 Jul; 12(7):681-691. PubMed ID: 31159608 [No Abstract] [Full Text] [Related]
7. On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson's Disease Psychosis. Pagan FL; Schulz PE; Torres-Yaghi Y; Pontone GM CNS Drugs; 2024 May; 38(5):333-347. PubMed ID: 38587586 [TBL] [Abstract][Full Text] [Related]
8. Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis. Panchal SC; Ondo WG Curr Psychiatry Rep; 2018 Jan; 20(1):3. PubMed ID: 29374325 [TBL] [Abstract][Full Text] [Related]
9. On the discovery and development of pimavanserin: a novel drug candidate for Parkinson's psychosis. Hacksell U; Burstein ES; McFarland K; Mills RG; Williams H Neurochem Res; 2014 Oct; 39(10):2008-17. PubMed ID: 24682754 [TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease psychosis: symptoms, management, and economic burden. Hermanowicz N; Edwards K Am J Manag Care; 2015 Aug; 21(10 Suppl):s199-206. PubMed ID: 26296199 [TBL] [Abstract][Full Text] [Related]
19. Parkinson's Disease Psychosis and the Marketing of Pimavanserin. Daeschler D; Fugh-Berman A Int J Soc Determinants Health Health Serv; 2024 Jul; 54(3):272-284. PubMed ID: 38592164 [TBL] [Abstract][Full Text] [Related]